|
1
|
Fuster MM and Esko JD: The sweet and sour
of cancer: Glycans as novel therapeutic targets. Nat Rev Cancer.
5:526–542. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ishida H, Togayachi A, Sakai T, Iwai T,
Hiruma T, Sato T, Okubo R, Inaba N, Kudo T, Gotoh M, et al: A novel
beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which
synthesizes poly-N-acetyllactosamine, is dramatically upregulated
in colon cancer. FEBS Lett. 579:71–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kannagi R, Izawa M, Koike T, Miyazaki K
and Kimura N: Carbohydrate-mediated cell adhesion in cancer
metastasis and angiogenesis. Cancer Sci. 95:377–384. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang C, Zhou J, Wu S, Shan Y, Teng S and
Yu L: Cloning and tissue distribution of the human B3GALT7 gene, a
member of the beta1, 3-Glycosyltransferase family. Glycoconj J.
21:267–273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ni J, Jiang Z, Shen L, Gao L, Yu M, Xu X,
Zou S, Hua D and Wu S: β3GnT8 regulates the metastatic potential of
colorectal carcinoma cells by altering the glycosylation of CD147.
Oncol Rep. 31:1795–1801. 2014.PubMed/NCBI
|
|
6
|
Tang W, Chang SB and Hemler ME: Links
between CD147 function, glycosylation, and caveolin-1. Mol Biol
Cell. 15:4043–4050. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang W, Luo WJ, Zhu P, Tang J, Yu XL, Cui
HY, Wang B, Zhang Y, Jiang JL, Chen ZN, et al: Modulation of
CD147-induced matrix metalloproteinase activity: Role of CD147
N-glycosylation. Biochem J. 449:437–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun J and Hemler ME: Regulation of MMP-1
and MMP-2 production through CD147/extracellular matrix
metalloproteinase inducer interactions. Cancer Res. 61:2276–2281.
2001.PubMed/NCBI
|
|
9
|
Jiang Z, Hu S, Hua D, Ni J, Xu L, Ge Y,
Zhou Y, Cheng Z and Wu S: β3GnT8 plays an important role in CD147
signal transduction as an upstream modulator of MMP production in
tumor cells. Oncol Rep. 32:1156–1162. 2014.PubMed/NCBI
|
|
10
|
Angel P and Karin M: The role of Jun, Fos
and the AP-1 complex in cell-proliferation and transformation.
Biochim Biophys Acta. 1072:129–157. 1991.PubMed/NCBI
|
|
11
|
Wisdom R, Johnson RS and Moore C: c-Jun
regulates cell cycle progression and apoptosis by distinct
mechanisms. EMBO J. 18:188–197. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vogt PK: Fortuitous convergences: The
beginnings of JUN. Nat Rev Cancer. 2:465–469. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wertz IE, O'Rourke KM, Zhang Z, Dornan D,
Arnott D, Deshaies RJ and Dixit VM: Human De-etiolated-1 regulates
c-Jun by assembling a CUL4A ubiquitin ligase. Science.
303:1371–1374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Z, Ge Y, Zhou J, Xu L and Wu SL:
Subcellular localization and tumor distribution of human
beta3-galactosyltransferase by beta3GalT7 antiserum. Hybridoma.
29:141–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Shen L, Yang L, Hu S, Xu L and Wu
S: High expression of β3GnT8 is associated with the metastatic
potential of human glioma. Int J Mol Med. 33:1459–1468.
2014.PubMed/NCBI
|
|
17
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Freitas Junior JC and Morgado-Díaz JA:
The role of N-glycans in colorectal cancer progression: Potential
biomarkers and therapeutic applications. Oncotarget. 7:19395–19413.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mitsui Y, Yamada K, Hara S, Kinoshita M,
Hayakawa T and Kakehi K: Comparative studies on glycoproteins
expressing polylactosamine-type N-glycans in cancer cells. J Pharm
Biomed Anal. 70:718–726. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sameshima T, Nabeshima K, Toole BP,
Yokogami K, Okada Y, Goya T, Koono M and Wakisaka S: Expression of
emmprin (CD147), a cell surface inducer of matrix
metalloproteinases, in normal human brain and gliomas. Int J
Cancer. 88:21–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu S, Chu D, Zhang Y, Wang X, Gong L, Han
X, Yao L, Lan M, Li Y and Zhang W: EMMPRIN/CD147 expression is
associated with disease-free survival of patients with colorectal
cancer. Med Oncol. 30:3692013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan Y, He B, Song G, Bao Q, Tang Z, Tian F
and Wang S: CD147 silencing via RNA interference reduces tumor cell
invasion, metastasis and increases chemosensitivity in pancreatic
cancer cells. Oncol Rep. 27:2003–2009. 2012.PubMed/NCBI
|
|
23
|
Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN
and Chan HC: The involvement of HAb18G/CD147 in regulation of
store-operated calcium entry and metastasis of human hepatoma
cells. J Biol Chem. 276:46870–46877. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karamouzis MV, Konstantinopoulos PA and
Papavassiliou AG: The activator protein-1 transcription factor in
respiratory epithelium carcinogenesis. Mol Cancer Res. 5:109–120.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lopez-Bergami P, Huang C, Goydos JS, Yip
D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson
S and Ronai Z: Rewired ERK-JNK signaling pathways in melanoma.
Cancer Cell. 11:447–460. 2007. View Article : Google Scholar : PubMed/NCBI
|
